
一、基本信息
孙扬永,男,1980年1月出生,医学博士,硕士生导师,镇江市第一人民医院(江苏大学附属人民医院),副科主任,副主任医师。镇江市“金山英才”医学领域高层次引进人才,镇江市“169”工程学术技术骨干,江苏省医师协会心血管外科医师委员,江苏省研究型医院协会心血管内外科一体化专业委员会委员,江苏省医学会心血管外科学大血管外科学组成员,江苏省医学会心血管外科学先心病学组成员。擅长心脏瓣膜疾病、冠心病、急慢性主动脉夹层、先天性心脏病等心血管疾病及食管疾病、肺癌、肺结节、纵隔肿瘤等常见普胸疾病的诊断治疗。常规开展体外循环下二尖瓣置换/修复、主动脉瓣置换、三尖瓣成形、冠状动脉旁路移植、先天性心脏病的矫治,DSA下主动脉腔内覆膜支架植入术,胸腔镜下食管癌根治术,胸腔镜下肺叶切除术,肺段切除术等。参与多项国自然基金项目、上海市自然科学基金项目等,主持镇江市科技局项目一项。邮箱:sunyangyong0116@163.com
二、教育经历
1999.9—2004.7,江苏大大学,医学院,临床专业,学士
2004.9—2007.7,江苏大学,医学院,外科学专业,硕士
2019.9—2022.7,海军军医大学(第二军医大学),外科学专业,博士
三、研究方向
主要从事心脏大血管疾病的发表机制以及相关药物治疗的研究
四、承担项目
镇江市科学技术局“靶向MKNK2的小分子化合物SM1-71-plus改善糖尿病心肌损伤的作用和药效评价”。项目号:JC2024032,2024/08-2026/8,4万,主持
五、代表性论著
1. Zhao An#,Yangyong Sun#,Xiaodong Yang#,Jingwen Zhou, Yongchao Yu Boyao Zhang, Zhiyun Xu,Yuming Zhu,Guokun Wang.Enhanced expression of miR-20a driven by nanog exacerbated the degradation of extracellular matrix in thoracic aortic dissection. Non-coding RNA Research.2024 May 09.doi.org/10.1016/j.ncrna.2024.05.006.
2. Sun YY,Li S, Liu C, Pan Y, Xiao Y. Identification of a methyltransferase-related long noncoding RNA signature as a novel prognosis biomarker for lung adenocarcinoma. Aging (Albany NY). 2024 May 20;16(10):8747-8771. doi: 10.18632/aging.205837. Epub 2024 May 20. PMID: 38771129; PMCID: PMC11164517.
3. Sun Y#, Wang H#, Xu H#, Xu X, Wang G*, Xu Z*. Outcomes of reoperation for total arch replacement combined with frozen elephant trunk after previous cardiovascular surgery. Asian J Surg. 2023;46(1):314-320.
4. Xu H, Wang H, Wu L, Xu T, Han L, Lu F, Li B,Sun Y*, Xu Z*. Prognostic Value of Systemic Inflammation Response Index in Acute Type A Aortic Dissection. World J Surg.2023;47(10):2554-2561.
5. An Z#, Zhong K#,Sun Y#, Han L, Xu Z, Li B. Risk factors for in-hospital mortality after total arch procedure in patients with acute type A aortic dissection.Front Cardiovasc Med. 2023;10:1149907.
6. Yu M#,Sun Y#, Shan X#, Yang F, Chu G, Chen Q, Han L, Guo Z*, Wang G*. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy. Cell Mol Biol Lett. 2022;27(1):85.
7. Xu H#, Li Y#, Wang H#, Yuan Y, Chen D,Sun Y*, Xu Z*. Systemic immune-inflammation index predicted short-term outcomes in ATAD patients undergoing surgery. J Card Surg. 2022;37(4):969-975.
8. Xu H#, Wang H#, Chen S#, Chen Q, Xu T, Xu Z*,Sun Y*. Prognostic Value of Modified Model for End-Stage Liver Disease Score in Patients Undergoing Isolated Tricuspid Valve Replacement. Front Cardiovasc Med. 2022;9:932142.
9. Sun Y#, Xu H#,Xu X#, Wang H#, Yuan Y, An Z, Xu Z*, Wang G*. A novel method to obtain rat aortic media for primary culture of rat aortic smooth muscle cells. In Vitro Cell Dev Biol Anim. 2021;57(7):726-734.
10. Sun Y#, Yang F#, Liu Y#, Yu M, Wu F*, Wang G*. Di-2-ethylhexyl phthalate induces heart looping disorders during zebrafishdevelopment.2021;37(7):391-397.
11. An Z,Sun YY, Fan RX, Yu SQ, Zhu JM, Han QQ, Han L. Extensive Arch Repair with a Novel Two-Branched Stent Graft in Acute Type A Aortic Dissection. Ann Thorac Cardiovasc Surg. 2022;28(4):255-261.
12. YuanY,Sun Y, Li N, Han L, Lu F, Li B, Xu Z. Long-Term Outcomes of Bioprosthetic and Mechanical Tricuspid Valve Replacement after Left-Sided Valves Surgery. Ann Thorac Cardiovasc Surg. 2023;29(6):307-314.
13. Wang H,Sun Y, Peng J, Zhao L, Xu H, Xu Z, Zhang G. An Analysis of Total Arch Re-Replacement After Proximal Aortic Surgery. Heart Surg Forum. 2022;25(4):E616-E620.
14. Li Q, Gao Y, Zhang J, Tang Y,Sun Y, Wu L, Wu H, Shen M, Liu X, Han L, Xu Z.Crosslinking and functionalization of acellular patches via the self-assembly of copper@tea polyphenol nanoparticles.Regen Biomater. 2022:9:rbac030.
15. 孙扬永,王国坤,徐志云.腹主动脉瘤发病的细胞学机制[J].江苏医药,2021,47(07):736-738.
16. 李芹,孙扬永,吴昊,刘晓红,徐志云.茶多酚处理脱细胞牛心包组织支架作为人工食管修补材料的可行性.中国组织工程研究,27(12):1832-1836[2022-04-02
六、获奖情况
1. 2022年镇江市“金山英才”医学领域高层次引进人才;
2. 2023年镇江市“169”工程学术技术骨干;